In The Media

NeuroScientific Biopharmaceuticals
and EmtinB in the media

As EmtinB continues to demonstrate positive results and nears clinical trials,
NeuroScientific Biopharmaceuticals has been gaining media coverage for our innovative approach as well as sharemarket performance.